These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38541302)

  • 1. Pap Smear Cancer Coverage in Brazilian Capitals including the Pandemic Period Caused by the SARS-CoV-2 Virus: Ecological Study.
    Costa AS; Baracat EC; Júnior JMS; Sorpreso ICE
    Int J Environ Res Public Health; 2024 Mar; 21(3):. PubMed ID: 38541302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time trend analysis and impacts of the COVID-19 pandemic on mammography and Papanicolaou test coverage in Brazilian state capitals.
    da Silva AG; Silva TPRD; Vasconcelos NM; Santos FMD; Oliveira GC; Malta DC
    BMC Womens Health; 2024 Jul; 24(1):436. PubMed ID: 39085895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trends and inequalities in self-reported cervical cancer screening in Brazilian capitals from 2011 to 2020].
    Vieira YP; Viero VDSF; Vargas BL; Nunes GO; Machado KP; Neves RG; Saes MO
    Cad Saude Publica; 2022; 38(9):e00272921. PubMed ID: 36287397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colon and rectal cancer mortality in Brazilian capitals, 1980-1997].
    das Neves FJ; Mattos IE; Koifman RJ
    Arq Gastroenterol; 2005; 42(1):63-70. PubMed ID: 15976914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of hospital utilization in the Unified Health System in six Brazilian capitals: comparison between the year before and the first six first months of the COVID-19 pandemic.
    Portela MC; de Aguiar Pereira CC; Lima SML; de Andrade CLT; Martins M
    BMC Health Serv Res; 2021 Sep; 21(1):976. PubMed ID: 34535135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human Development Index and secondary prevention of breast and cervical cancer: an ecological study].
    Sadovsky AD; Poton WL; Reis-Santos B; Barcelos MR; Silva IC
    Cad Saude Publica; 2015 Jul; 31(7):1539-50. PubMed ID: 26248108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study.
    Balan L; Secosan C; Sorop VB; Pirtea M; Cimpean AM; Chiriac D; Balan C; Borsi E; Iorga A; Pirtea L
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929526
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of the COVID-19 Pandemic on Cervical Cancer Screening in São Paulo State, Brazil.
    Martins TR; Witkin SS; Mendes-Corrêa MC; Godoy AS; Cury L; Balancin ML; Ab'Saber AM; Peres SV; Messias S; Tozetto Mendoza TR; Longatto-Filho A
    Acta Cytol; 2023; 67(4):388-394. PubMed ID: 36682351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of cervical cancer control actions within Brazil and its regions based on data recorded in the Brazilian Unified National Health System].
    Silva GAE; Alcantara LLM; Tomazelli JG; Ribeiro CM; Girianelli VR; Santos ÉC; Claro IB; Almeida PF; Lima LD
    Cad Saude Publica; 2022; 38(7):e00041722. PubMed ID: 35894365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inequalities in mammography and Papanicolaou test coverage: a time-series study.
    Malta DC; Prates EJS; Silva AGD; Santos FMD; Oliveira GC; Vasconcelos NM; Cristo EB
    Sao Paulo Med J; 2020; 138(6):475-482. PubMed ID: 33111921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Quality of Pap Smears from the Brazilian Cervical Cancer Screening Program According to the Human Development Index.
    Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG
    Cancer Prev Res (Phila); 2020 Mar; 13(3):299-308. PubMed ID: 31836602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
    Ferreira HNC; Capistrano GN; Morais TNB; Costa KTDS; Quirino ALS; Costa RLPD; Andrade FB
    PLoS One; 2023; 18(10):e0278011. PubMed ID: 37883452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
    Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
    BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic and regional inequalities of pap smear coverage.
    Manica ST; Drachler Mde L; Teixeira LB; Ferla AA; Gouveia HG; Anschau F; Oliveira DL
    Rev Gaucha Enferm; 2016 Mar; 37(1):e52287. PubMed ID: 26982680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the program life in traffic and new zero-tolerance drinking and driving law on the prevalence of driving after alcohol abuse in Brazilian capitals: An interrupted time series analysis.
    Guimarães RA; de Morais Neto OL; Dos Santos TMB; Mandacarú PMP; Machado EL; Caiaffa WT; Filho PRP; Aquino ÉC; Reisen VA
    PLoS One; 2023; 18(10):e0288288. PubMed ID: 37862323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program.
    Demarteau N; Breuer T; Standaert B
    Pharmacoeconomics; 2012 Apr; 30(4):337-53. PubMed ID: 22409292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013.
    Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG
    BMC Cancer; 2018 Feb; 18(1):126. PubMed ID: 29394915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and cervical cancer: a comparison of the period before and during the COVID-19 pandemic.
    Stevanato KP; Santos LD; Pelloso FC; Borghesan DHP; Consolaro MEL; de Almeida R; Huber IMT; Egger P; Alarcão ACJ; de Souza RR; Ribeiro HF; Camparoto CW; Bitencourt MR; Borba PB; Silva LL; de Barros Carvalho MD; Pelloso SM
    BMC Womens Health; 2024 Sep; 24(1):485. PubMed ID: 39227848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Cancer Screening-Past, Present, and Future.
    Wentzensen N; Clarke MA
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):432-434. PubMed ID: 33857013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.